The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Pharmaceutical Composition For The Treatment Of Pulmonary Arterial Hypertension - EP3897646

The patent EP3897646 was granted to Actelion Pharmaceuticals on May 22, 2024. The application was originally filed on Dec 20, 2019 under application number EP19832954A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3897646

ACTELION PHARMACEUTICALS
Application Number
EP19832954A
Filing Date
Dec 20, 2019
Status
Granted And Under Opposition
Apr 19, 2024
Publication Date
May 22, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

GENERICS UKFeb 21, 2025ELKINGTON AND FIFEADMISSIBLE
SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETIFeb 21, 2025SONNENHAUSERADMISSIBLE
SANDOZFeb 7, 2025ELKINGTON AND FIFEADMISSIBLE

Patent Citations (6) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTWO2010018549
INTERNATIONAL-SEARCH-REPORTWO2018089804
INTERNATIONAL-SEARCH-REPORTWO2018153513
OPPOSITIONWO2010018549
OPPOSITIONWO2018089804
OPPOSITIONWO2018153513

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents